Scientific Publications

The International Federation of Psoriasis Association’s 6th World Psoriasis & Psoriatic Arthritis Conference 2021
Wednesday, June 30, 2021 – Saturday,
July 3, 2021

Download Poster Presentation


2021 Virtual AAN Annual Meeting
Saturday, April 17, 2021 – Thursday,
April 22, 2021

Download Poster Presentation

Download Audio Recording

30th Annual Meeting of the Society for Virology
Wednesday, March 24, 2021 – Friday,
March 26, 2021

Download Poster Presentation


Clinical relevance of intestinal barrier dysfunction in common gastrointestinal diseases
Andreas Muehler, Jason R Slizgi, Hella Kohlhof, Manfred Groeppel, Evelyn Peelen and Daniel Vitt
World Journal of Gastrointestinal Pathophysiology; 2020 December 12; 11(6):
114-130
Published: December 12, 2020
doi: https://dx.doi.org/10.4291/wjgp.v11.i6.114

Download Article


IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro
Friedrich Hahn, Christina Wangen, Sigrun Häge, Antonia Sophia Peter, Gerhard Dobler, Brett Hurst, Justin Julander, Jonas Fuchs, Zsolt Ruzsics, Klaus Überla, Hans-Martin Jäck, Roger Ptak, Andreas Muehler, Manfred Gröppel, Daniel Vitt, Evelyn Peelen, Hella Kohlhof and Manfred Marschall
Viruses 2020, 12, 1394
Published: December 5, 2020
doi: 10.3390/v12121394

Download Article


MSVirtual2020 / 8th Joint ACTRIMS-ECTRIMS Meeting
Friday, September 11, 2020 – Sunday, September 13, 2020

Download Poster Presentation

Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro
Yu-Jin Kim, Beatrice Cubitt, Yingyun Cai, Jens H. Kuhn, Daniel Vitt, Hella Kohlhof, Juan C. de la Torre
Viruses 2020, 12, 821
Published: July 29, 2020
doi: 10.3390/v12080821

Download Article



Vidofludimus calcium, a next generation DHODH inhibitor for the treatment of relapsing-remitting multiple sclerosis
Andreas Muehler, Evelyn Peelen, Hella Kohlhof, Manfred Gröppel, Daniel Vitt
Multiple Sclerosis and Related Disorders, Volume 43, 2020
Published online: May 6, 2020
ISSN 2211-0348 / doi: https://doi.org/10.1016/j.msard.2020.102129.

Download Article


Safety, Tolerability and Pharmacokinetics of Vidofludimus calcium (IMU-838) After Single and Multiple Ascending Oral Doses in Healthy Male Subjects
Andreas Muehler, Hella Kohlhof, Manfred Groeppel & Daniel Vitt
European Journal of Drug Metabolism and Pharmacokinetics
Published online: May 2, 2020
ISSN 0378-7966 / doi: 10.1007/s13318-020-00623-7

Download Article


Design, Rationale and Baseline Characteristics of the Randomized Double-blind Phase II Clinical Trial of Vidofludimus calcium (IMU-838) in Relapsing-Remitting Multiple Sclerosis (4558)
Robert Fox, Heinz Wiendl, Nicola De Stefano, Johann Sellner, Andreas Mühler
Neurology Apr 2020, 94 (15 Supplement) 4558
Published online: April 14, 2020

Link to Abstract


IBD Innovate Conference: Product Development for Crohn’s and Colitis
Wednesday, December 4, 2019
New York

Download Presentation


United European Gastroenterology Week (UEGW)
Tuesday, October 22, 2019
Barcelona, Spain

Download Poster Presentation


The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study
Andreas Muehler, Hella Kohlhof, Manfred Groeppel & Daniel Vitt
Drugs in R&D
Published online: October 16, 2019
ISSN 1174-5886 / doi: 10.1007/s40268-019-00286-z

Download Article


Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2019
Wednesday, September 11, 2019
Stockholm, Sweden

Download Poster Presentation


GI Inflammatory Diseases Summit (GIIDS)
Monday, June 24, 2019
Boston

Download Presentation


2nd Conference on Molecular Mechanisms of Inflammation
Tuesday, June 4, 2019
Trondheim, Norway

Download Poster Presentation